Selma Karime Castillo-Vazquez

Ms. Selma Karime Castillo-Vazquez

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Nadia RiveroNadia Rivero
Nadia Rivero
EZEmmanuel Alejandro Zepeda-Arzate
Emmanuel Alejandro Zepeda-Arzate
SCSelma Karime Castillo-Vazquez
Selma Karime Castillo-Vazquez
PPPatrick Fleischmann de la Parra
Patrick Fleischmann de la Parra
JHJessica Hernández-Pineda
Jessica Hernández-Pineda
CVCarlos Verjan
Carlos Verjan
Aging is the result of the accumulation of a wide variety of molecular and cellular damages over time, meaning that “the more damage we accumulate, the higher the possibility to develop age-related diseases”. Therefore, to reduce the incidence of such diseases and improve human health, it becomes important to find ways to combat such damage. In this sense, geroprotectors have been suggested as molecules that could slow down or prevent age-related diseases. On the other hand, nutraceuticals are another set of compounds that align with the need to prevent diseases and promote health since they are biologically active molecules (occurring naturally in food) that, apart from having a nutritional role, have preventive properties, such as antioxidant, anti-inflammatory and antitumoral, just to mention a few. Therefore, in the present review using the specialized databases Scopus and PubMed we collected information from articles published from 2010 to 2023 in order to describe the role of nutraceuticals during the aging process and, given their role in targeting the hallmarks of aging, we suggest that they are potential geroprotectors that could be consumed as part of our regular diet or administered additionally as nutritional supplements.

19 June 2025 in Metabolites
Verified
Journal Article
Open access
PDF file
SCSelma Karime Castillo-Vazquez
Selma Karime Castillo-Vazquez
BPBerenice Palacios-Gonzalez
Berenice Palacios-Gonzalez
Marcela Vela-AmievaMarcela Vela-Amieva
Marcela Vela-Amieva
IGIsabel Ibarra González
Isabel Ibarra González
RMRicardo Morales
Ricardo Morales
Nadia RiveroNadia Rivero
Nadia Rivero
Background/Objectives: Insomnia has been widely associated with cognitive impairment (CI). However, the relationship between the two entities (insomnia and CI) is poorly understood. In this context, adults with insomnia show metabolic changes, including alterations in the catabolism of branched-chain amino acids, glycerophospholipids, and glutathione and glutamate biosynthesis. Nevertheless, aging itself induces metabolic changes that may be amplified by chronic diseases that compromise the health of the elderly. Therefore, in the present study we aim to characterise metabolomic profiles of insomnia and CI alone in order to address a significant gap in current research regarding the pathways through which insomnia may lead to CI in older persons. Methods: In this study we perform a targeted metabolomics analysis (UPLC-MS) on 80 serum samples from the Cohort of Obesity, Sarcopenia, and Frailty of Older Mexican Adults (COSFOMA); these samples were classified into four groups (control, insomnia, CI, and insomnia + CI). Results: Our results show that insomnia increases the concentration of acylcarnitines (C10, C8, C14, C12:1, C18:1 and C18) as compared to CI group, while older persons with CI show a decrease the concentration of the acylcarnitines C16, C10 and C8. Finally, individuals with both conditions (insomnia + CI) show that only the concentration of the acylcarnitine C16 decreases compared to controls. Conclusions: Taken together, our results shed light on the relevance of insomnia on lipid metabolism in older persons.

1 July 2026 in Geriatrics
Verified
Journal Article
Open access
PDF file
SCSelma Karime Castillo-Vazquez
Selma Karime Castillo-Vazquez
Nadia RiveroNadia Rivero
Nadia Rivero
CVCarlos Verjan
Carlos Verjan
JHJazmin Camacho Hernández
Jazmin Camacho Hernández
DHDaniel Alejandro Hernández-Pando
Daniel Alejandro Hernández-Pando
Background/Objectives: Sarcopenia significantly increases the risk of hospitalization and mortality in older adults. However, the prevalence by sex varies across populations and according to the criteria used by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2). Hence, in the current study, we aim to characterize the prevalence of sarcopenia by jointly evaluating all three diagnostic domains in a Mexican cohort of older adults subscribed to a health insurance plan. Methods: We performed binomial and multinomial regression models, ordinal logistic regression, and multiple linear regression from the data corresponding to muscle mass (ASMI), muscle strength (handgrip dynamometry), and physical performance (SPPB) from 556 Mexican older adults (62.2% female; 72.27 ± 6.35 y.o.) categorized by sarcopenia severity according to the EWGSOP2. Results: Men exhibited significantly higher absolute muscle mass and strength across all categories (p < 0.001). Additionally, our statistical analyses demonstrate that age, but not sex, is involved in sarcopenia severity in this population. Moreover, when analyzing the disaggregated EWGSOP2 domains, the results demonstrate that sex is significantly associated with muscle mass (ASMI) and muscle strength (Handgrip strength). Conclusions: These results suggest that sex only influences both muscle mass (ASMI) and muscle strength (handgrip strength) while sarcopenia severity only depends on age.

24 December 2024
Verified
Book Chapter
Closed access
PDF file
CVCarlos Verjan
Carlos Verjan
RRRuth Rincón-Heredia
Ruth Rincón-Heredia
APAugusto César Poot-Hernández
Augusto César Poot-Hernández
José Jaime Martínez-MagañaJosé Jaime Martínez-Magaña
José Jaime Martínez-Magaña
JMJanitza L. Montalvo-Ortiz
Janitza L. Montalvo-Ortiz
Nadia RiveroNadia Rivero
Nadia Rivero